RE:RE:Replicel Twitter 13.07.2022Timeline for the Dermaprecise submission for FDA Approval: Possibly
Status of the Shiseido Arbitration (3 months to deadline): the biggest Hope of us is the Shiseido Arbitration because it isnt in the hands of Replicel. A lawyer will Finalize this arbitration so no Big delays and we will get exciting news in fall this year. I don't think that Replicel will give us an Update in this Point because it will take this 3 months. As we already told Replicel has the Upper Hand in this case- they will win.
Will Yofoto proceed with trials in RCS-01 and RCT-01 ? I think they had problems of COVID and the Technologys of Replicel Are on Hold.
Any progress in finding partners in Japan ? Possible
Will there ever be any RCH-01 trials outside of the Shiseido trials ? They Arent in a Financial situation to start any trials...
---
it is all about Shiseido arbitration. They will win i am sure. Otherwise the insiders wouldnt load up their shares. We can say about Lee Buckler and his Team Everything Bad But they have a high knowledge of the laws they Are very convinced about the Case against Shiseido otherwise they wouldnt terminate this agreement. We will See Stock valuation oder Replicel about 1-5$ in Winter 2022. I feel sorry For the others and myself invested to early. This recent valuation of 0.085$ is a joke, wished to Buy in now. All companys (YOFOTO 0,95$, Mainpointe 0,65$) invested so much higher. This should give us the real worth of Replicel now (ca. 0,5-0,7$)